Aspira Pathlab Peer Comparison

BSE: 540788

₹91.50

₹1.75 (1.95%)

As on 28-Aug-2026IST

Market cap

₹94 Cr

Revenue (TTM)

₹26 Cr

P/E Ratio

--

P/B Ratio

7.7

Div. Yield

0 %

Edit

	Aspira Pathlab	Lotus Eye Hosp	NG	Soni Medicare	Samsrita Labs
Market cap (₹ Cr)	94	231	38	30	25
Revenue (₹ Cr)	26	57	17	24	0
Net Profit (₹ Cr)	-0.45	0.15	1.93	-3.62	-8.72
Net Margin (%)	-1.72	0.26	10.69	-15.36	-17,442.00
RoE (%)	-3.41	0.26	5.30	--	-60.02
Price to Earnings	--	1,536.85	19.86	--	--
Price-To-Book	7.72	3.79	1.13	-11.34	2.20

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Aspira Pathlab	Lotus Eye Hosp	NG	Soni Medicare	Samsrita Labs
Operating Revenue	22.61	49.56	16.55	29.84	--
Total Income	23.01	50.86	24.55	31.18	0.00
Total Expenditure	18.61	46.00	14.69	29.92	0.26
EBITDA	4.00	3.56	1.86	-0.08	-0.26
Depreciation	1.48	3.01	0.61	0.50	0.00
EBIT	2.52	0.55	1.25	-0.58	-0.26
Interest	0.36	0.48	0.10	0.99	0.00
Other Income	0.40	1.30	8.00	1.35	--
Exceptional Items	0.00	0.01	--	--	--
Profit before Tax	2.56	1.38	9.14	-0.22	-0.26
Provision for Tax	0.00	0.64	1.40	-0.04	--
Profit after Tax	2.56	0.74	7.74	-0.19	-0.26

Liabilities (₹ Cr)

	Aspira Pathlab	Lotus Eye Hosp	NG	Soni Medicare	Samsrita Labs
Shareholder's Funds	11.18	60.00	38.52	1.30	11.97
Minority Interest	0.00	--	--	--	--
Non-Current Liabilities	2.30	2.07	0.66	10.49	0.11
Current Liabilities	2.34	7.42	2.44	10.38	3.48
Total Liabilities	17.46	69.57	41.62	22.17	15.57

Assets (₹ Cr)

	Aspira Pathlab	Lotus Eye Hosp	NG	Soni Medicare	Samsrita Labs
Non-Current Assets	8.46	57.92	37.58	8.39	10.02
Current Assets	5.87	11.57	4.04	13.78	5.54
Total Assets	17.46	69.57	41.62	22.17	15.57
Total Debt*	1.21	0.61	1.78	10.52	2.43
Net Current Assets	3.53	4.15	1.59	3.39	2.06
Contingent Liabilities	1.12	0.82	0.09	0.03	--

Cashflow (₹ Cr)

	Aspira Pathlab	Lotus Eye Hosp	NG	Soni Medicare	Samsrita Labs
Cash From Operating Activities	1.83	2.70	1.81	1.47	-0.23
Cash Flow from Investing Activities	0.12	-3.99	-1.23	-0.52	--
Cash from Financing Activities	-0.99	-1.60	-0.62	-0.24	0.22
Net Cash Inflow / Outflow	0.95	-2.89	-0.03	0.71	0.00

Ratios

Profitability Ratios

	Aspira Pathlab	Lotus Eye Hosp	NG	Soni Medicare	Samsrita Labs
ROCE (%)	19.27	3.10	23.83	6.58	-1.79
ROE (%)	18.13	1.24	20.73	-12.79	-2.14
ROA (%)	32.34	1.09	18.98	-0.89	-1.67
EBIT Margin (%)	11.12	9.81	59.58	4.24	--
Net Margin (%)	11.12	1.45	31.53	-0.60	--
Cash Profit Margin (%)	0.00	7.56	50.48	1.06	--

Growth Ratios

	Aspira Pathlab	Lotus Eye Hosp	NG	Soni Medicare	Samsrita Labs
Revenue Growth (%)	66.60	2.81	-1.99	9.48	-100.00
EBIT Growth (%)	611.07	-38.76	51.11	607.46	-4.35
Net Profit Growth (%)	175.69	-74.63	53.75	88.92	-3.83
EPS Growth (%)	175.69	-74.63	53.75	88.92	-8.58
Book Value Growth (%)	19.94	1.00	6.59	-19.64	-2.32

Valuation Ratios

	Aspira Pathlab	Lotus Eye Hosp	NG	Soni Medicare	Samsrita Labs
Price / Earnings	39.29	196.62	7.06	0.00	0.00
Price / Book Value	7.45	2.42	1.42	15.72	1.73
Dividend Yield (%)	0.00	0.00	2.15	0.00	0.00
EV/EBITDA	23.33	29.18	5.48	22.85	-90.20
Market Cap (₹ Cr)	87.73	145.37	54.63	20.42	--

Solvency Ratios

	Aspira Pathlab	Lotus Eye Hosp	NG	Soni Medicare	Samsrita Labs
Debt to Equity	0.10	0.01	0.05	8.10	0.20
Short term debt to equity ratio	--	--	0.05	0.31	0.20
Current Ratio	2.51	1.56	1.65	1.33	1.59
Quick Ratio	2.27	1.04	1.56	1.24	1.59
Interest Coverage	8.11	3.88	88.23	0.78	-182.25

Operating Efficiency Ratios

	Aspira Pathlab	Lotus Eye Hosp	NG	Soni Medicare	Samsrita Labs
Debtors to sales (%)	11.14	2.67	2.58	29.37	--
Asset Turnover	2.86	0.73	0.41	1.43	0.00
Receivable days	38.11	9.50	6.31	96.98	--
Inventory Days	7.95	25.93	15.24	8.69	--
Payable days	72.32	80.52	0.00	251.51	--
Cash Conversion Cycle	-26.26	-45.09	21.54	-145.84	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.